Filing Details

Accession Number:
0001140361-16-079947
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-09-15 19:48:18
Reporting Period:
2016-09-13
Filing Date:
2016-09-15
Accepted Time:
2016-09-15 19:48:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
827809 Qlt Inc QLTI Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1370042 Stonepine Capital, L.p. 919 Nw Bond Street
Suite 204
Bend OR 97703
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-09-13 61,704 $1.54 5,706,704 No 4 P Direct
Common Stock Acquisiton 2016-09-14 56,864 $1.55 5,763,568 No 4 P Direct
Common Stock Acquisiton 2016-09-15 14,928 $1.55 5,778,496 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
Footnotes
  1. The filers (the "Filers") are Stonepine Capital, L.P. (the "Fund"), Stonepine Capital Management, LLC (the "General Partner"), Jon M. Plexico and Timothy P. Lynch. The General Partner is the general partner and investment adviser of the Fund. Mr. Plexico and Mr. Lynch are the General Partner's managers and control persons. These securities are held directly by the Fund for the benefit of its investors and are indirectly beneficially owned by the General Partner and Mr. Plexico and Mr. Lynch as the General Partner's control persons. The Fund is filing this Form 4 for itself and the other Filers.
  2. The Filers are filing this Form 4 jointly, but not as a group, and each expressly disclaims membership in a group within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended. Each Filer disclaims beneficial ownership of these securities except to the extent of that Filer's pecuniary interest therein.